Skip to content

Evaluate the effectiveness of computer therapy for people with aphasia who have auditory comprehension difficulties

Evaluating the efficacy of a Self-Administered, Remotely Monitored, Therapy for People with Post-Stroke Aphasia who present with Auditory Sentence Processing Deficits

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN97782093
Enrollment
12
Registered
2019-07-16
Start date
2017-06-20
Completion date
Unknown
Last updated
2022-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke aphasia specifically auditory comprehension impairment Circulatory System Sequelae of stroke, not specified as haemorrhage or infarction

Interventions

This is a case-series experimental two-phase cross-over treatment design, comparing a self-administered rehabilitation programme targeting language deficits experienced by people with post-stroke apha
mild, moderate and severe. Each allocation is enclosed in a sealed opaque envelope, and not opened until participant allocation. The research team is blind to the allocation process.

Sponsors

University College Cork
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults, over 18 years of age 2. Presenting with acquired language deficits (aphasia) post-stroke 3. At least 6 months post-onset of stroke 4. Have daily access to a PC or Laptop computer and have Internet access (as course is online) 5. Can give fully informed consent 6. Not receiving Speech and Language Therapy at the time of the study but may attend support services e.g. charity social groups which don't include Speech and Language Therapy input.

Exclusion criteria

Exclusion criteria: Bilateral hearing loss below 40dB on any frequency between 250Hz and 4kHz

Design outcomes

Primary

MeasureTime frame
1. Aphasia type and severity are measured using the Western Aphasia Battery at baseline, post-phase 1, post-phase 2, follow up at 4 weeks and 16 weeks. 2. Sentence comprehension is measured using a Test of Reception of Grammar at baseline, post-phase 1, post-phase 2, follow up at 4 weeks and 16 weeks. 3. Auditory comprehension sentence, paragraph and conversation levels are measured using e-ACT – a language outcome measure developed for the study and administered on a computer and eye-tracker at baseline, post-phase 1, post-phase 2, follow up at 4 weeks and 16 weeks.

Secondary

MeasureTime frame
1. Neuropsychological status is measured using the Repeatable Battery for the Assessment of Neurological Status at baseline, post-phase 1, post-phase 2, follow up at 4 weeks and 16 weeks. 2. Quality of life following Stroke is measured using Stroke and Aphasia Quality of Life Scale-39 at baseline, post-phase 1, post-phase 2, follow up at 4 weeks and 16 weeks. 3. Repetition is measured using the Psycholinguistic Assessment of Language Processing in Aphasia subtest 7 (word repetition), 8 (non-word repetition) and 12 (sentence repetition) at baseline, post-phase 1, post-phase 2, follow up at 4 weeks and 16 weeks. 4. Written naming is measured using the Psycholinguistic Assessment of Language Processing in Aphasia subtest 53 at baseline, post-phase 1, post-phase 2, follow up at 4 weeks and 16 weeks. 5. Quality of life measure developed for the study that investigated the quality of life related to specific everyday language activities at baseline, post-phase 1, post-phase 2, follow up at 4 weeks and 16 weeks. 6. Usability and cognitive workload are measured using a feedback questionnaire midway through each phase. 7. Usability is measured using a structured observation midway through each phase. 8. Participants' perspective of usability and engagement with the programmes is measured using interviews midway through each phase and in a final exit interview, 4 weeks after the end of Phase 2.

Countries

Ireland

Contacts

Public ContactHelen Kelly
helen.kelly@ucc.ie00353(0)214901746

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026